These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 10729656)
1. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656 [TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241 [TBL] [Abstract][Full Text] [Related]
3. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Vergis EN; Hayden MK; Chow JW; Snydman DR; Zervos MJ; Linden PK; Wagener MM; Schmitt B; Muder RR Ann Intern Med; 2001 Oct; 135(7):484-92. PubMed ID: 11578151 [TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia. Kohler P; Eshaghi A; Kim HC; Plevneshi A; Green K; Willey BM; McGeer A; Patel SN; PLoS One; 2018; 13(3):e0193926. PubMed ID: 29566004 [TBL] [Abstract][Full Text] [Related]
6. The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan. Jiang HL; Zhou Z; Wang LS; Fang Y; Li YH; Chu CI Int J Infect Dis; 2017 Jan; 54():18-24. PubMed ID: 27836794 [TBL] [Abstract][Full Text] [Related]
7. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346 [TBL] [Abstract][Full Text] [Related]
8. Vancomycin-resistant enterococcus in end-stage renal disease. Brady JP; Snyder JW; Hasbargen JA Am J Kidney Dis; 1998 Sep; 32(3):415-8. PubMed ID: 9740157 [TBL] [Abstract][Full Text] [Related]
9. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome. Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476 [TBL] [Abstract][Full Text] [Related]
10. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Stosor V; Peterson LR; Postelnick M; Noskin GA Arch Intern Med; 1998 Mar; 158(5):522-7. PubMed ID: 9508230 [TBL] [Abstract][Full Text] [Related]
11. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study. Cho SY; Lee DG; Choi SM; Kwon JC; Kim SH; Choi JK; Park SH; Park YJ; Choi JH; Yoo JH BMC Infect Dis; 2013 Oct; 13():504. PubMed ID: 24164924 [TBL] [Abstract][Full Text] [Related]
12. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607 [TBL] [Abstract][Full Text] [Related]
13. Impact of Enterococcal Bacteremia in Liver Transplant Recipients. Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients. Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080 [TBL] [Abstract][Full Text] [Related]
16. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977 [TBL] [Abstract][Full Text] [Related]
17. VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis. Prematunge C; MacDougall C; Johnstone J; Adomako K; Lam F; Robertson J; Garber G Infect Control Hosp Epidemiol; 2016 Jan; 37(1):26-35. PubMed ID: 26434609 [TBL] [Abstract][Full Text] [Related]
18. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826 [TBL] [Abstract][Full Text] [Related]
19. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin. Cunha BA; Mickail N; Eisenstein L Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808 [TBL] [Abstract][Full Text] [Related]
20. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Kapur D; Dorsky D; Feingold JM; Bona RD; Edwards RL; Aslanzadeh J; Tutschka PJ; Bilgrami S Bone Marrow Transplant; 2000 Jan; 25(2):147-52. PubMed ID: 10673672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]